Related references
Note: Only part of the references are listed.Leukemia-specific delivery of mutant NOTCH1 targeted therapy
Giovanni Roti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22
F. Arruga et al.
LEUKEMIA (2017)
Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia
Giulia Fabbri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome
Elisa Albi et al.
TUMORI (2017)
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome
Elisa Albi et al.
TUMORI (2017)
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation
F. Pozzo et al.
LEUKEMIA (2016)
The clerodane diterpene casearin J induces apoptosis of T-ALL cells through SERCA inhibition, oxidative stress, and interference with Notch1 signaling
C. De Ford et al.
CELL DEATH & DISEASE (2016)
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL
Filomena De Falco et al.
Oncotarget (2015)
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation
F. De Falco et al.
LEUKEMIA (2015)
The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells
M. Lopez-Guerra et al.
LEUKEMIA (2015)
The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells
Dawson M. Gerhardt et al.
GENES & DEVELOPMENT (2014)
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia
P. Sportoletti et al.
LEUKEMIA (2014)
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia
F. Arruga et al.
LEUKEMIA (2014)
Complementary Genomic Screens Identify SERCA as a Therapeutic Target in NOTCH1 Mutated Cancer
Giovanni Roti et al.
CANCER CELL (2013)
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation
Emanuela Rosati et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion
Stefano Baldoni et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
Giulia Fabbri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome
N. Villamor et al.
LEUKEMIA (2013)
A novel NOTCH1 PEST domain mutation in a case of chronic lymphocytic leukemia
Paolo Sportoletti et al.
LEUKEMIA & LYMPHOMA (2013)
The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy
Valeria Tosello et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2012)
Molecular pathogenesis of chronic lymphocytic leukemia
Gianluca Gaidano et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy
A. H. Nwabo Kamdje et al.
BLOOD CANCER JOURNAL (2012)
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E. M. Herman et al.
BLOOD (2011)
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
Giulia Fabbri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Notch signalling in solid tumours: a little bit of everything but not all the time
Prathibha Ranganathan et al.
NATURE REVIEWS CANCER (2011)
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
Sarah E. M. Herman et al.
BLOOD (2010)
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL
Paolo Sportoletti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Therapeutic antibody targeting of individual Notch receptors
Yan Wu et al.
NATURE (2010)
Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors
Miguel Aste-Amezaga et al.
PLOS ONE (2010)
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
Emanuela Rosati et al.
BLOOD (2009)
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation
Mauro Di Ianni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing notch signaling
Francesco Liotta et al.
STEM CELLS (2008)
A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease
Jan Duerig et al.
CANCER RESEARCH (2007)
Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines
Takeaki Dohda et al.
EXPERIMENTAL CELL RESEARCH (2007)
Activity of the notch-signalling pathway in circulating human chronic lymphocytic leukaemia cells
M. Hajdu et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Interleukin-7-engineered mesenchymal cells: In vitro effects on naive T-cell population
Paolo Sportoletti et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Recent insights into the role of Notch signaling in tumorigenesis
KG Leong et al.
BLOOD (2006)
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: Justification for risk-adapted therapy
JC Byrd et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Notch signaling regulates the differentiation of post-mitotic intestinal epithelial cells
V Zecchini et al.
GENES & DEVELOPMENT (2005)
Modulation of notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation
J Milano et al.
TOXICOLOGICAL SCIENCES (2004)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
HF Dovey et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Effect of the antianginal drug bepridil on intracellular Ca2+ release and extracellular Ca2+ influx in human neutrophils
LW Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Calcium depletion dissociates and activates heterodimeric notch receptors
MD Rand et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
